[1]
Tahir Siddique et al. 2025. A Randomized Controlled Clinical Trial to Compare the Efficacy of Pralidoxime When Given in Continuous Infusion Versus Intermittent Dose in Terms of Symptomatic Improvement Over a Given Time Scale. Journal of Health, Wellness and Community Research. 3, 2 (Apr. 2025), 1–10. DOI:https://doi.org/10.61919/hvyjkd47.